The IMH Executive Committee is advisory to the Director of the Institute, providing advice and support to the Director on operational aspects of all activities of the Institute. Additionally, the Executive Committee provides advice and guidance to the Director on matters relating to development and execution of vision and strategic priorities, as well as fund raising activities.
The specific responsibilities of the IMH Executive Committee are:
- To participate in the development of a strategic plan and support the Director in identifying a clear vision and strategic priorities for the Institute
- To advise and assist the Director on operationalizing the implementation of the IMH’s strategic priorities
- To advise the Director on decisions related to operational aspects of the IMH
- To assist in enhancing the UBC Institute of Mental Health’s public profile
- To assist with fundraising activities benefiting and sustaining the UBC Institute of Mental Health
- To facilitate links between the Institute and external communities including family and patient advocacy groups, appropriate government bodies, mental health professionals, provincial, national and international partners
- To bring external viewpoints and suggest approaches regarding the challenges and opportunities facing the UBC Institute of Mental Health.
Chair, Dr. Lakshmi N. Yatham
Dr. Yatham is a professor and Department Head in the Department of Psychiatry, Director of the UBC Institute of Mental Health, and Regional Head of Psychiatry and Regional Program Medical Director for Mental Health and Addictions at Vancouver Coastal Health and Providence Health Care. He has an Executive MBA from the Sauder School of Business and a wealth of leadership experience in academic, healthcare and professional organizations. He has held leadership positions such as the President for the International Society for Bipolar Disorders, and is now the President of the World Federation of Societies of Biological Psychiatry.
Dr. Yatham’s major areas of research interest include neurobiology and treatment of bipolar disorder. His research has contributed to several advances in understanding and treatment of bipolar disorder including disease progression, importance of early intervention in arresting disease progression, and development of new treatments. He has published about 300 peer reviewed papers and is one of the few most highly cited researchers in psychiatry/psychology in the world. He is on the editorial boards of a number of international journals and a Scientific Advisory Board member of the International Bipolar Foundation and Harvard’s Dauten Family Center for Bipolar Studies. Dr. Yatham has been the lead for publication of the CANMAT bipolar guidelines which are widely cited and adopted for use by clinicians from around the world. He has received numerous national and international awards for his contributions to research and leadership in the field of bipolar disorders.
Dr. Jehannine Austin
Jehannine is a Professor in Psychiatry & Medical Genetics at UBC, where she holds the Canada Research Chair in Translational Psychiatric Genomics. She is executive director of PHSA's BC Mental Health and Addictions Research Institute. Her research work involves studying the impact of genetic counseling for people with psychiatric disorders and their families. She founded the worlds first specialist psychiatric genetic counseling service that has won an award for its impact on patient outcomes, and in addition to peer-reviewed publications, has written a book and won awards for teaching, innovation, leadership, and research. She is a member of the College of the Royal Society of Canada, and a Fellow of the Canadian Academy of Health Sciences.
Dr. Liisa Galea
Liisa Galea is a Professor in the Department of Psychology, a member of the Centre for Brain Health, Director of the Graduate Program in Neuroscience, and a Scientific Advisor at Women’s Health Research Institute at the University of British Columbia. My research investigates how sex hormones influence brain health and disease in both females and males. The main goal of my research is to improve brain health for women and men by examining the influence of sex and sex hormones on normal and diseased brain states such as depression and Alzheimer’s disease.
Dr. Trevor Hurwitz
Dr. Hurwitz completed his medical degree in Pretoria, South Africa followed by an internship in Johannesburg and a senior housemanship in Cape Town. He continued his studies in London, England and obtained certification in Internal Medicine. He completed a residency in Psychiatry at the University of British Columbia in 1980 and a residency in Neurology at Boston University in 1982.
Currently Dr. Hurwitz is a Clinical Professor in the Department of Psychiatry at the University of British Columbia. He is the Director of the B.C. Neuropsychiatry Program and Chief-of-Service of West-1 at UBC Hospital, Vancouver. Dr. Hurwitz has a joint appointment in the Department of Medicine, Division of Neurology and practices as a clinical neurologist in addition to his primary commitment to inpatient and outpatient Neuropsychiatry.
Dr. Hurwitz’s work is mostly devoted to clinical practice, teaching and the promotion of the discipline of Neuropsychiatry with some research interests in the field of Neuropsychiatry.
Dr. Michael Krausz
Dr. Michael Krausz is originally from Hamburg, Germany, where he was trained at the University Medical Center Hamburg-Eppendorf. Following his training, he worked in three different clinical and research positions in general psychiatry.
In the mid 1990s, he became a founding director of the Centre of Interdisciplinary Addiction Research at the University of Hamburg and retained directorship at the centre until 2004. As a founding director, he was also responsible for the German Heroin Trial, the European Cocaine Project, and several other notable addiction-related trials.
He was also Editor-In-Chief of two well-established scientific journals; Suchttherapie and European Addiction Research respectively. He has also published more than 300 scientific papers to date. Dr. Krausz is also a founding member of the International Society of Addiction Medicine (ISAM) and is currently serving on the boards of the Section of Addiction and the Section of Public Policy for the World Psychiatric Association.
Michael relocated permanently to the Vancouver area in 2007 and became a professor of psychiatry and the University of British Columbia (UBC) as well as the LEEF Chair in Addiction Research at the Institute of Mental Health at UBC.
Dr. Raymond Lam
Dr. Raymond W. Lam is Professor and Associate Head for Research & International Affairs , and Residency Director of Scholarly Activity and Research Track, in the Department of Psychiatry, University of British Columbia (UBC) and Director of the Mood Disorders Centre at the Djavad Mowafaghian Centre for Brain Health in Vancouver. His research examines clinical and neurobiological factors in seasonal, treatment-resistant and workplace depression, clinical trials and guidelines, and eMentalHealth. Dr. Lam is also a lead investigator for the Canadian Biomarker Integration Network in Depression (CAN-BIND). His research is supported by many agencies including the Canadian Institutes of Health Research and by investigator-initiated industry research grants.
Dr. Sophia Frangou
Dr. Frangou is a Professor and the Associate Head of Research and International Affairs in the UBC Department of Psychiatry, and is the President’s Excellence Chair in Brain Health at the Djavad Mowafaghian Centre for Brain Health, where she leads the Translational Neuroimaging and Clinical Neuroscience Program in Mental Health. Dr. Frangou has authored more than 250 scientific papers that have attracted over 16,000 citations, and she is the recipient of the Colvin Prize for Outstanding Achievement in Mood Disorders Research.